BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15128810)

  • 1. Immunological characteristics associated with the protective efficacy of antibodies to ricin.
    Maddaloni M; Cooke C; Wilkinson R; Stout AV; Eng L; Pincus SH
    J Immunol; 2004 May; 172(10):6221-8. PubMed ID: 15128810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized.
    Song K; Mize RR; Marrero L; Corti M; Kirk JM; Pincus SH
    PLoS One; 2013; 8(4):e62417. PubMed ID: 23638075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel biological-based assay for the screening of neutralizing antibodies to ricin.
    Furukawa-Stoffer TL; Mah DC; Cherwonogrodzky JW; Weselake RJ
    Hybridoma; 1999 Dec; 18(6):505-11. PubMed ID: 10626679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.
    McGuinness CR; Mantis NJ
    Infect Immun; 2006 Jun; 74(6):3463-70. PubMed ID: 16714577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values.
    Rosenfeld R; Alcalay R; Mechaly A; Lapidoth G; Epstein E; Kronman C; J Fleishman S; Mazor O
    Protein Eng Des Sel; 2017 Sep; 30(9):611-617. PubMed ID: 28472478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to ricin: in vitro inhibition of toxicity and utility as diagnostic reagents.
    Dertzbaugh MT; Rossi CA; Paddle BM; Hale M; Poretski M; Alderton MR
    Hybridoma (Larchmt); 2005 Oct; 24(5):236-43. PubMed ID: 16225423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody prophylaxis against the in vivo toxicity of ricin in mice.
    Chanh TC; Romanowski MJ; Hewetson JF
    Immunol Invest; 1993 Feb; 22(1):63-72. PubMed ID: 8440524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralising antibodies against ricin toxin.
    Prigent J; Panigai L; Lamourette P; Sauvaire D; Devilliers K; Plaisance M; Volland H; Créminon C; Simon S
    PLoS One; 2011; 6(5):e20166. PubMed ID: 21633505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro.
    O'Hara JM; Mantis NJ
    J Immunol Methods; 2013 Sep; 395(1-2):71-8. PubMed ID: 23774033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies.
    Yermakova A; Vance DJ; Mantis NJ
    PLoS One; 2012; 7(9):e44317. PubMed ID: 22984492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies.
    Legler PM; Compton JR; Hale ML; Anderson GP; Olson MA; Millard CB; Goldman ER
    MAbs; 2017 Jan; 9(1):43-57. PubMed ID: 27660893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neutralizing activities of a single domain camelid antibody (VHH) specific for ricin toxin's binding subunit (RTB).
    Herrera C; Vance DJ; Eisele LE; Shoemaker CB; Mantis NJ
    PLoS One; 2014; 9(6):e99788. PubMed ID: 24918772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication.
    Mantis NJ; McGuinness CR; Sonuyi O; Edwards G; Farrant SA
    Infect Immun; 2006 Jun; 74(6):3455-62. PubMed ID: 16714576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to purified ricin A-chain: production and properties.
    Leonard JE; Tanney LE; Collins ML; Royston I; Taetle R
    Hybridoma; 1987 Apr; 6(2):135-49. PubMed ID: 3570304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.
    Neal LM; O'Hara J; Brey RN; Mantis NJ
    Infect Immun; 2010 Jan; 78(1):552-61. PubMed ID: 19858297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against ricin: effects on toxin function.
    Colombatti M; Pezzini A; Colombatti A
    Hybridoma; 1986; 5(1):9-19. PubMed ID: 3957360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.